Congressman Neal Dunn, M.D.'s Veterans Prostate Cancer
Treatment and Research Act unanimously passed in the House of Representatives
on Tuesday.
Prostate cancer is the number one cancer diagnosed in the
Veterans Health Administration, with over 489,000 veterans undergoing
treatment. The bill will direct the Secretary of Veterans Affairs to establish
a national clinical pathway for prostate cancer, a standardized system of care
for the treatment of what is the most commonly diagnosed cancer in the veterans'
health system.
“The last thing any veteran should face is yet another enemy
– prostate cancer,” said Dr. Dunn. “I’m pleased to see my bill pass today. The
key to overcoming prostate cancer is early detection. Veterans deserve a system
that streamlines the pathway from early detection to successful treatment. I’m
grateful that my colleagues recognized the importance of my bill and have
joined me in defeating this deadly adversary.”
Veterans who have been in contact with toxins, such as Agent
Orange, are at higher risk for prostate cancer. Establishing a clinical pathway
will standardize treatment options and result in improved outcomes for these
patients. Additionally, the bill creates a real-time registry to track patient
progress and will allow patients greater access to cutting edge clinical
trials.
No comments:
Post a Comment